These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7247379)

  • 21. Pharmacokinetic analysis of selected antibiotics in calves.
    Luderer JR; Aber RC; Myers JL; Prophet GA; Pierce WS
    Trans Am Soc Artif Intern Organs; 1982; 28():159-63. PubMed ID: 7164233
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid-chromatographic assay of aminoglycoside antibiotics in serum.
    Anhalt JP; Brown SD
    Clin Chem; 1978 Nov; 24(11):1940-7. PubMed ID: 709826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.
    Mayhew JW; Gorbach SL
    Antimicrob Agents Chemother; 1978 Dec; 14(6):851-55. PubMed ID: 369455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial fluid concentrations of cefoxitin, cephazolin and cefamandole.
    Landau Z; Rubinstein E; Halkin H
    J Antimicrob Chemother; 1980 Sep; 6(5):657-63. PubMed ID: 7410286
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
    White LO; Holt HA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1997 Mar; 39(3):355-61. PubMed ID: 9096185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of cefamandole, cefoxitin, ampicillin and gentamicin against 419 bacteria isolated from blood of patients with sepsis.
    Mirrett S; Reller LB
    Chemotherapy; 1980; 26(6):436-45. PubMed ID: 7408556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
    Fradet G; Brister S; Richards GK; Prentis J; Brown RA; Chiu RC; Mulder DS
    J Vasc Surg; 1986 Mar; 3(3):535-9. PubMed ID: 3512862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-pancreatic juice barrier to antibiotic excretion.
    Burns GP; Stein TA; Kabnick LS
    Am J Surg; 1986 Feb; 151(2):205-8. PubMed ID: 3946753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cefamandole nafate on the toxicity of tobramycin.
    Wold JS; Turnipseed SA; Broddle WD; Owen NV
    Antimicrob Agents Chemother; 1977 Oct; 12(4):465-9. PubMed ID: 921240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro inactivation of aminoglycosides by cephalosporin antibiotics.
    Wright DN; Marble DA; Saxon B; Johnson CC; Bosso JA; Matsen JM
    Arch Pathol Lab Med; 1988 May; 112(5):526-8. PubMed ID: 3358654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefoxitin and cefamandole levels in the human bile.
    Basoli A; Fiocca F; Chirletti P; Schietroma M; Pierini N; Caprioli A; Speranza V
    Ital J Surg Sci; 1985; 15(4):347-53. PubMed ID: 3830955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetical, histological, and histochemical investigation on the ototoxicity of gentamicin, tobramycin, and amikacin (author's transl)].
    Federspil P; Schätzle W; Tiesler E
    Arch Otorhinolaryngol; 1977 Jul; 217(2):147-66. PubMed ID: 578730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.
    Armstrong GC; Wise R; Brown RM; Hancox J
    Antimicrob Agents Chemother; 1981 Sep; 20(3):356-8. PubMed ID: 7030200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.
    du T Naudé W; van den Ende J; Botha P; Forder A; Hyland J; de Klerk HC; Neiteler BF; Koornhof HJ; Robinson R; Robins-Browne R; Block C; Appelbaum PC; Africa CW; van Rensburg AJ; Jooste PJ; Crewe-Browne H; Fernandez A
    S Afr Med J; 1977 Nov; 52(20):798-800. PubMed ID: 305120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
    Stark GB; Eiermann T; Langmaack H; Daschner F
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1182-4. PubMed ID: 7105995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
    Gentry LO; Wood BA; Martin MD; Smythe J
    Scand J Infect Dis Suppl; 1980; suppl 25():96-100. PubMed ID: 7010544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of cephalosporins and cefoxitin with serum creatinine determination.
    Hyneck ML; Berardi RR; Johnson RM
    Am J Hosp Pharm; 1981 Sep; 38(9):1348-52. PubMed ID: 7282720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.